Is Allogene Therapeutics, Inc. technically bullish or bearish?
As of August 18, 2025, Allogene Therapeutics, Inc. shows a mildly bearish trend with mixed technical indicators, having returned 3.42% over the past week and 11.01% over the past month, but is down 43.19% year-to-date compared to the S&P 500's 12.22% gain.
As of 18 August 2025, the technical trend for Allogene Therapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, with key indicators showing mixed signals: the MACD is mildly bullish on both weekly and monthly time frames, while the moving averages indicate a mildly bearish trend on the daily. The Bollinger Bands suggest a bullish outlook weekly but a mildly bearish one monthly. Additionally, the KST is mildly bullish weekly but bearish monthly, and the Dow Theory indicates a mildly bearish trend weekly with no trend monthly.In terms of performance, the stock has returned 3.42% over the past week and 11.01% over the past month, outperforming the S&P 500, which returned 1.05% and 2.33% respectively. However, the year-to-date return is -43.19%, significantly underperforming the S&P 500's 12.22%. Over the longer term, the stock has seen substantial declines, with a 5-year return of -96.82% compared to the S&P 500's 96.61%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
